Levels of serum‐circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre‐eclampsia, gestational hypertension, and/or fetal growth restriction

Aim We aimed to investigate maternal serum angiogenic marker profiles within 1 week prior to delivery in cases of gestational hypertension (GH), pre‐eclampsia (PE), and/or fetal growth restriction (FGR) with different clinical conditions. Methods We enrolled 165 women with singleton pregnancy. The participants were classified based on three characteristics: (i) proteinuria (GH and PE); (ii) FGR (PE with FGR [PE + FGR], PE alone, and FGR alone); and (iii) onset (early onset PE [EO PE] and late‐onset PE [LO PE]). All sera were obtained within 1 week prior to delivery, and soluble fms‐like tyrosine kinase 1 (sFlt‐1), soluble endoglin (sEng), and placental growth factor (PlGF) were measured with enzyme‐linked immunosorbent assay. Results (i) In PE, a significantly increased sFlt‐1, sEng, and sFlt‐1 to PlGF ratio (sFlt‐1/PlGF) and significantly decreased PlGF were observed compared with GH and Term control, whereas in GH, only sFlt‐1/PlGF was significantly higher than Term control. (ii) In PE + FGR, similar changes were more markedly shown compared with PE alone. The FGR alone group exhibited similar tendencies as PE, although significant differences were found in PlGF and sEng levels. (iii) In EO PE, significant changes were observed in all factors compared with LO PE or Term control, while no significant change in PlGF levels was observed between LO PE and Term control. Conclusion We demonstrated that the levels of circulating angiogenic factors just before delivery are correlated with the severity of hypertensive disorders of pregnancy and FGR. Profiling these specific markers may contribute to better understanding of the clinical conditions in individual patients and their pathogenesis.